Dawn J Gay Selected Research

2- (4'- methoxybiphenyl- 4- sulfonylamino)- 3- methylbutyric acid

1/2004

Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dawn J Gay Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2004 - 10/2003
2	Neoplasms (Cancer) 01/2004 - 10/2003

Drug/Important Bio-Agent (IBA)

1	2- (4'- methoxybiphenyl- 4- sulfonylamino)- 3- methylbutyric acidIBA 01/2004
1	N- hydroxy- 2- (((4'- methoxyphenyl)sulfonyl)benzylamino)- 3- methylbutanamideIBA 01/2004
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 10/2003
1	Matrix Metalloproteinase InhibitorsIBA 10/2003